CLDX
Price
$24.60
Change
-$0.09 (-0.36%)
Updated
Jan 30 closing price
Capitalization
1.63B
28 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$16.52
Change
-$1.07 (-6.08%)
Updated
Jan 30 closing price
Capitalization
1.7B
71 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLDX vs NRIX

Header iconCLDX vs NRIX Comparison
Open Charts CLDX vs NRIXBanner chart's image
Celldex Therapeutics
Price$24.60
Change-$0.09 (-0.36%)
Volume$568.29K
Capitalization1.63B
Nurix Therapeutics
Price$16.52
Change-$1.07 (-6.08%)
Volume$1.56M
Capitalization1.7B
CLDX vs NRIX Comparison Chart in %
View a ticker or compare two or three
VS
CLDX vs. NRIX commentary
Feb 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Buy and NRIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 02, 2026
Stock price -- (CLDX: $24.60 vs. NRIX: $16.52)
Brand notoriety: CLDX and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 80% vs. NRIX: 97%
Market capitalization -- CLDX: $1.63B vs. NRIX: $1.7B
CLDX [@Biotechnology] is valued at $1.63B. NRIX’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRIX is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 2 TA indicator(s) are bullish while NRIX’s TA Score has 3 bullish TA indicator(s).

  • CLDX’s TA Score: 2 bullish, 5 bearish.
  • NRIX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а -5.09% price change this week, while NRIX (@Biotechnology) price change was -10.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.27%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +33.81%.

Reported Earning Dates

CLDX is expected to report earnings on Mar 02, 2026.

NRIX is expected to report earnings on Apr 14, 2026.

Industries' Descriptions

@Biotechnology (-4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.7B) and CLDX($1.64B) have the same market capitalization . CLDX YTD gains are higher at: -9.426 vs. NRIX (-12.915). NRIX (-248.7M) and CLDX (-252.86M) have comparable annual earnings (EBITDA) . CLDX has more cash in the bank: 583M vs. NRIX (429M). CLDX has less debt than NRIX: CLDX (2.62M) vs NRIX (56.5M). NRIX has higher revenues than CLDX: NRIX (83.7M) vs CLDX (2.6M).
CLDXNRIXCLDX / NRIX
Capitalization1.64B1.7B96%
EBITDA-252.86M-248.7M102%
Gain YTD-9.426-12.91573%
P/E RatioN/AN/A-
Revenue2.6M83.7M3%
Total Cash583M429M136%
Total Debt2.62M56.5M5%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXNRIX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSHIX16.33-0.01
-0.06%
Transamerica Multi-Asset Income I
FSBKX22.38-0.21
-0.93%
Federated Hermes Global Allocation R
HLMNX29.32-0.36
-1.21%
Harding Loevner International Eq Inv
FEBIX16.68-0.24
-1.40%
First Eagle Global Income Builder I
ACEAX10.82-0.29
-2.61%
AB All China Equity A

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with KURA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-0.36%
KURA - CLDX
56%
Loosely correlated
-1.22%
VIR - CLDX
56%
Loosely correlated
-4.37%
NUVL - CLDX
55%
Loosely correlated
+0.45%
XNCR - CLDX
54%
Loosely correlated
-2.34%
NRIX - CLDX
53%
Loosely correlated
-6.08%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-6.08%
KYMR - NRIX
65%
Loosely correlated
-1.65%
KURA - NRIX
55%
Loosely correlated
-1.22%
XNCR - NRIX
54%
Loosely correlated
-2.34%
OCUL - NRIX
53%
Loosely correlated
-8.14%
IDYA - NRIX
53%
Loosely correlated
-2.42%
More